57631-013-10 : NDC 2025 Code

57631-013-10 : Guaifenesin And Dextromethorphan Hydrobromide ( Guaifenesin And Dextromethorphan Hydrobromide )

Additionally :

You can get information about “57631-013-10” NDC code in 57631-013-10 in HTML format

HTML | 57631-013-10 in TXT (Plain Text) format

TXT | 57631-013-10 in PDF (Portable Document Format)

PDF | 57631-013-10 in XML format

XML formats.

NDC Code : 57631-013-10 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "57631-013-10",
    "PackageDescription": "26500 TABLET in 1 BOX (57631-013-10) ",
    "NDC11Code": "57631-0013-10",
    "ProductNDC": "57631-013",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Guaifenesin And Dextromethorphan Hydrobromide",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Guaifenesin And Dextromethorphan Hydrobromide",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210113",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "InvaTech Pharma Solutions LLC",
    "SubstanceName": "DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN",
    "StrengthNumber": "20; 400",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-10-03",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20210113",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}